The page is the record's research on the issuer — no analyst, no rating, no view. # NERVGEN PHARMA CORP. (NASDAQ: NGEN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is NERVGEN PHARMA CORP., listed on NASDAQ under the ticker NGEN. Its ISIN is US64082X2036. Its LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US. Its security type is recorded as non-operating entity type (other), and its sector is 2834 Pharmaceutical Preparations. Its segment and jurisdiction are not on the record. Its status is listed, not halted. ## The disclosure read The record holds 32 filings across 21 filing days in the window 2025-11-08 to 2026-11-08: 3 prospectus, 12 regulatory filing and 17 results. The median gap between filing days is 12.5 days. The latest filing is a results filing dated 2026-10-16, which is 23 days before the record date of 2026-11-08. On NASDAQ the record holds 4359 issuers with a median cadence gap of 6.0 days, a median of 52 filings and a median latency of 5.0 days. In sector 2834 Pharmaceutical Preparations the record holds 526 issuers with a median cadence gap of 6.0 days, a median of 63.0 filings and a median latency of 4.0 days. The issuer's cadence gap of 12.5 days is above both medians, its filing count of 32 is below both medians, and its latency of 23 days is above both medians. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds two listing lines, both dated 2026-01-07. It holds no delisting lines and no name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable on this record. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the investor-relations pages read, and the count is 0. ## Open research No openly published research notes were found, and the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2021, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date of the market at 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001751912.json (identity.name) - https://mcp.us-cm-kg.ai/events/NASDAQ/NGEN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/NGEN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/NGEN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp